FR6707M - - Google Patents

Info

Publication number
FR6707M
FR6707M FR59635A FR59635A FR6707M FR 6707 M FR6707 M FR 6707M FR 59635 A FR59635 A FR 59635A FR 59635 A FR59635 A FR 59635A FR 6707 M FR6707 M FR 6707M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR59635A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR59635A priority Critical patent/FR6707M/fr
Application granted granted Critical
Publication of FR6707M publication Critical patent/FR6707M/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR59635A 1966-04-29 1966-04-29 Expired FR6707M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR59635A FR6707M (fr) 1966-04-29 1966-04-29

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR59635A FR6707M (fr) 1966-04-29 1966-04-29

Publications (1)

Publication Number Publication Date
FR6707M true FR6707M (fr) 1969-02-17

Family

ID=8607442

Family Applications (1)

Application Number Title Priority Date Filing Date
FR59635A Expired FR6707M (fr) 1966-04-29 1966-04-29

Country Status (1)

Country Link
FR (1) FR6707M (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0282696A2 (fr) * 1987-02-18 1988-09-21 Steigerwald Arzneimittelwerk Gmbh Emploi de dérivés de pyridoxine pour la prophylaxie et le traitement de l'hyperlipémie et de l'athérosclérose
WO1999053928A1 (fr) * 1998-04-16 1999-10-28 University Of Manitoba Traitement de l'hypertension iatrogene et liee au vieillissement et compositions pharmaceutiques utiles a cet effet

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0282696A2 (fr) * 1987-02-18 1988-09-21 Steigerwald Arzneimittelwerk Gmbh Emploi de dérivés de pyridoxine pour la prophylaxie et le traitement de l'hyperlipémie et de l'athérosclérose
EP0282696A3 (en) * 1987-02-18 1989-06-14 Ulrich Dr. Speck Use of pyridoxine derivatives in the prophylaxis and treatment of hyperlipemia and atherosclerosis
WO1999053928A1 (fr) * 1998-04-16 1999-10-28 University Of Manitoba Traitement de l'hypertension iatrogene et liee au vieillissement et compositions pharmaceutiques utiles a cet effet

Similar Documents

Publication Publication Date Title
AU5917865A (fr)
AU424443B2 (fr)
AU428063B2 (fr)
AU417216B2 (fr)
AU421822B2 (fr)
AU433222B2 (fr)
AU612166A (fr)
AU5895065A (fr)
AU6703465A (fr)
BE674987A (fr)
BE675139A (fr)
BE693287A (fr)
BE674882A (fr)
BE674792A (fr)
BE674777A (fr)
BE694608A (fr)
BE674713A (fr)
BE673316A (fr)
BE666282A (fr)
BE662818A (fr)
BE654686A (fr)
BE637138A (fr)
BE626310A (fr)
BE624223A (fr)
BE624001A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse